Sentry’s Chief Revenue Officer published in Pharmaceutical Executive
William T. Sander, PharmD, Chief Revenue Officer of Sentry Data Systems, has published an article in Pharmaceutical Executive magazine. The article, “Data as Currency: The Value of Longitudinal Data for Pharma,” discusses how pharmaceutical companies can use longitudinal data to their advantage, including for more accurate representation of medication effects, to reduce costs and narrow the focus of R&D efforts, and for improved post-market monitoring.
William is an accomplished leader with more than 25 years in the healthcare industry. In his current role, he is responsible for managing customer relationships in addition to market expansion.
